Back to Search Start Over

Neurofibromatosis 1 - Mutant microglia exhibit sexually-dimorphic cyclic AMP-dependent purinergic defects.

Authors :
Elmadany N
Logiacco F
Buonfiglioli A
Haage VC
Wright-Jin EC
Schattenberg A
Papawassiliou RM
Kettenmann H
Semtner M
Gutmann DH
Source :
Neurobiology of disease [Neurobiol Dis] 2020 Oct; Vol. 144, pp. 105030. Date of Electronic Publication: 2020 Jul 29.
Publication Year :
2020

Abstract

As critical regulators of brain homeostasis, microglia are influenced by numerous factors, including sex and genetic mutations. To study the impact of these factors on microglia biology, we employed genetically engineered mice that model Neurofibromatosis type 1 (NF1), a disorder characterized by clinically relevant sexually dimorphic differences. While microglia phagocytic activity was reduced in both male and female heterozygous Nf1 mutant (Nf1+/-) mice, purinergic control of phagocytosis was only affected in male Nf1+/- mice. ATP-induced P2Y-mediated membrane currents and P2RY12-dependent laser lesion-induced accumulation of microglial processes were also only impaired in male, but not female Nf1+/-, microglia. These defects resulted from Nf1+/- male-specific defects in cyclic AMP regulation, rather than from changes in purinergic receptor expression. Cyclic AMP elevation by phosphodiesterase blockade restored the male Nf1+/- microglia defects in P2Y-dependent membrane currents and process motility. Taken together, these data establish a sex-by-genotype interaction important to microglia function in the adult mouse brain.<br />Competing Interests: Declaration of Competing Interest The authors declare no relevant conflicts of interest.<br /> (Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1095-953X
Volume :
144
Database :
MEDLINE
Journal :
Neurobiology of disease
Publication Type :
Academic Journal
Accession number :
32736084
Full Text :
https://doi.org/10.1016/j.nbd.2020.105030